Susquehanna International Group
NERV icon

Susquehanna International Group’s Minerva Neurosciences NERV Stock Holding History

Susquehanna International Group’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-17,400
Closed -$27.7K – 13168
2022
Q4 		$27.7K Sell
17,400
-200
-1% -$865 ﹤0.01% 11648
2022
Q3 		$162K Sell
17,600
-41,800
-70% -$248K ﹤0.01% 11132
2022
Q2 		$197K Buy
59,400
+38,025
+178% +$155K ﹤0.01% 10650
2022
Q1 		$142K Sell
21,375
-525
-2% -$3.22K ﹤0.01% 11608
2021
Q4 		$140K Sell
21,900
-4,075
-16% -$38.4K ﹤0.01% 11872
2021
Q3 		$362K Buy
25,975
+11,450
+79% +$172K ﹤0.01% 10161
2021
Q2 		$270K Buy
14,525
+9,375
+182% +$202K ﹤0.01% 11006
2021
Q1 		$120K Buy
5,150
+3,662
+246% +$91.5K ﹤0.01% 11773
2020
Q4 		$28K Sell
1,488
-2,150
-59% -$54.2K ﹤0.01% 10854
2020
Q3 		$93K Sell
3,638
-1,537
-30% -$41.5K ﹤0.01% 9952
2020
Q2 		$149K Sell
5,175
-42,025
-89% -$2.47M ﹤0.01% 9269
2020
Q1 		$2.27M Buy
47,200
+44,662
+1,760% +$2.69M ﹤0.01% 3738
2019
Q4 		$144K Buy
2,538
+750
+42% +$33.1K ﹤0.01% 8964
2019
Q3 		$111K Buy
1,788
+325
+22% +$18.4K ﹤0.01% 9507
2019
Q2 		$66K Buy
+1,463
New +$73.2K ﹤0.01% 9771
2019
Q1 		– Sell
-1,438
Closed -$78K – 9495
2018
Q4 		$78K Buy
+1,438
New +$105K ﹤0.01% 8324
2018
Q3 		– Sell
-1,788
Closed -$118K – 9900
2018
Q2 		$118K Buy
+1,788
New +$109K ﹤0.01% 8973
2017
Q3 		– Sell
-13,200
Closed -$935K – 9352
2017
Q2 		$935K Buy
13,200
+11,912
+925% +$771K ﹤0.01% 5406
2017
Q1 		$83K Buy
+1,288
New +$100K ﹤0.01% 8459

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM

Susquehanna International Group's NERV Position: Q1 2026 in Review

Susquehanna International Group opened a new position in Minerva Neurosciences (NERV) in Q1 2026: 119,131 shares worth $718K. The stake represents ﹤0.01% of the portfolio and ranks #8752 among its holdings. This is a return to the name: Susquehanna International Group previously reported a position in NERV as recently as Q3 2024.

Susquehanna International Group first reported a position in NERV in Q1 2016 and has held it in 20 quarters since. The position peaked at $1.51M in Q1 2020. 47 funds tracked by Wall St. Rank hold NERV as of Q1 2026.

  • Susquehanna International Group held 119,131 shares of Minerva Neurosciences worth $718K as of Q1 2026.
  • Minerva Neurosciences was a new Susquehanna International Group position in Q1 2026.
  • Minerva Neurosciences made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #8752 holding.
  • Susquehanna International Group first reported a position in Minerva Neurosciences in Q1 2016 and has held it in 20 quarters since.
  • Susquehanna International Group's Minerva Neurosciences position peaked at $1.51M in Q1 2020.
  • 47 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.